Moxifloxacin-induced Stevens-Johnson syndrome: A case report Moksifloksasin tedavisi sirasinda gelişen Stevens-Johnson sendromu: Bir olgu sunumu
Klimik Dergisi, cilt.29, sa.3, ss.136-137, 2016 (Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 29 Sayı: 3
- Basım Tarihi: 2016
- Doi Numarası: 10.5152/kd.2016.33
- Dergi Adı: Klimik Dergisi
- Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.136-137
- Anahtar Kelimeler: Moxifloxacin, Stevens-Johnson syndrome, adverse effects
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Stevens-Johnson syndrome is generally self-limiting, vesiculobullous and an acute-onset disease in which at least two mucosal areas are affected in addition to skin lesions It results in mortality in 3-18% of severe cases. In etiology, especially drugs, a variety of infectious agents, malignancy, and collagen vascular disease play a role. Although there is no specific treatment, removing the disease-causing agent and supportive treatment are the first treatment to be applied. Moxifloxacin is a frequently-preferred fourth generation quinolone in the treatment of pneumonia. In this study, a case of Stevens-Johnson syndrome developing after the use of moxifloxacin is presented.